-
1.
公开(公告)号:US20240350407A1
公开(公告)日:2024-10-24
申请号:US18762026
申请日:2024-07-02
申请人: SENSORY CLOUD, LLC
发明人: David A. Edwards , Tom Devlin
IPC分类号: A61K9/00 , A23L33/105 , A61K31/045 , A61K31/202 , A61K31/465 , A61K35/00 , A61K36/185 , A61K36/22 , A61K36/42 , A61K36/54 , A61K36/73 , A61K36/752 , A61K36/81 , A61K36/8962 , A61K36/899 , A61K36/9068 , A61K45/06 , A61M11/00 , A61M15/00 , A61M15/08
CPC分类号: A61K9/0078 , A23L33/105 , A61K31/045 , A61K31/202 , A61K31/465 , A61K35/00 , A61K36/185 , A61K36/22 , A61K36/42 , A61K36/54 , A61K36/73 , A61K36/752 , A61K36/81 , A61K36/8962 , A61K36/899 , A61K36/9068 , A61K45/06 , A61M11/003 , A61M15/0003 , A61M15/009 , A61M15/08 , A23V2002/00 , A61M2205/0294 , A61M2205/50
摘要: A composition of food or therapeutic and other substances for administration as a cloud of droplets, the cloud comprising readily-soluble droplets having a median size range of approximately 3 microns to approximately 20 microns, or 5 microns to 10 microns, or 6 microns to 10 microns, for introduction to an animal via an ortho-nasal or retro-nasal route. Agonists or antagonists may include one or more of the following: sodium iodide, sodium chloride, magnesium chloride, capsaicin, piperine, linalool, ground cinnamon, a cannabinoid, pimento, onion, clove, thyme, ginger, menthol, or TRPV antagonists, and chocolate, Irish cream, caramel, lemon, lime, mango, raspberry, watermelon, blueberry, strawberry, mint, popcorn, meat, Resolvin D2 or nicotine. Devices for delivering compositions as an aerosol are described.
-
公开(公告)号:US12090178B2
公开(公告)日:2024-09-17
申请号:US17831930
申请日:2022-06-03
发明人: Ashley Dombkowski , Christopher Cornyn , Albert E. Rosevear , Olivia M. Weihe , Cosmin M. Beliciu , Alexandra F. Russell , Antoinette de Senna
IPC分类号: A61K36/00 , A23L5/30 , A23L29/30 , A23L33/00 , A23L33/105 , A23L33/155 , A23L33/185 , A23L33/19 , A61K9/00 , A61K31/045 , A61K35/57 , A61K35/60 , A61K35/63 , A61K36/185 , A61K36/22 , A61K36/48 , A61K36/52 , A61K36/736 , A61K36/899
CPC分类号: A61K35/63 , A23L5/34 , A23L29/35 , A23L33/105 , A23L33/155 , A23L33/185 , A23L33/19 , A23L33/40 , A61K9/0056 , A61K31/045 , A61K35/57 , A61K35/60 , A61K36/185 , A61K36/22 , A61K36/48 , A61K36/52 , A61K36/736 , A61K36/899 , A23V2002/00
摘要: Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.
-
公开(公告)号:US11857591B2
公开(公告)日:2024-01-02
申请号:US17213419
申请日:2021-03-26
发明人: Jinjuan Wan , Hui Xue , Sheng Yuan , Aijun Xia , Yanhua Zhao , Meifang Shen
IPC分类号: A23K10/30 , A61K31/145 , A61K33/00 , A61K36/22 , A61K36/315 , A61K36/704 , A61K36/708 , A61P37/04 , A61K36/19 , A23K50/80
CPC分类号: A61K36/19 , A23K10/30 , A23K50/80 , A61K31/145 , A61K33/00 , A61K36/22 , A61K36/315 , A61K36/704 , A61K36/708 , A61P37/04
摘要: A composition for protecting liver, protecting intestines and enhancing immunity for freshwater fish is disclosed, including the following raw materials in parts by weight: 15˜27 parts of Andrographis herba, 18˜22 parts of Isatidis folium, 10˜15 parts of Polygonum hydropiper, 8˜12 parts of Rheum palmatum L., and 8˜12 parts of Galla chinensis. And the preparation and the application of the composition are disclosed. The composition of the disclosure has the effect of resisting bacteria, scavenge free radicals, clearing heat, detoxifying, preventing and treating enteritis and the like, which can effectively improve the immunity of the freshwater fish and ensure the health of the organism.
-
公开(公告)号:US20230371669A1
公开(公告)日:2023-11-23
申请号:US17196432
申请日:2021-03-09
IPC分类号: A45D19/00 , A61K36/55 , A61K36/889 , A61K36/47 , A61K36/71 , A61K36/63 , A61K36/185 , A61K36/736 , A61K36/31 , A61K36/8962 , A61K36/22 , A61K8/92 , A61K36/67 , A61K36/73 , B08B1/00 , A61N5/06
CPC分类号: A45D19/005 , A61K36/55 , A61K36/889 , A61K36/47 , A61K36/71 , A61K36/63 , A61K36/185 , A61K36/736 , A61K36/31 , A61K36/8962 , A61K36/22 , A61K8/922 , A61K36/67 , A61K36/73 , B08B1/002 , A61N5/0617 , A61K2236/15 , A61N2005/0657 , A61B2017/320004
摘要: A formula and method to counteract hair loss, where the formula is a mixture. The mixture consists of Flaxseed oil, Coconut oil, Castor oil, Nigella sativa oil, Olive oil, Sesame oil, Sweet Almond oil, Bitter Almond oil, Watercress oil, Jojoba oil, Garlic oil, Onion oil, and Pistacia lentiscus oil. The oils derived from seeds are cold rolled to produce the oil. The mixture is applied to the scalp after brushing and washing of the scalp area to be treated.
-
5.
公开(公告)号:US11806376B2
公开(公告)日:2023-11-07
申请号:US17690028
申请日:2022-03-09
发明人: Chongfu Wang , Kui Wang , Yu Gao
IPC分类号: A61K36/185 , A61P17/02 , A61K31/155 , A61K35/644 , A61K36/22 , A61K36/268 , A61K36/284 , A61K36/355 , A61K36/49 , A61K36/82 , A61K36/898
CPC分类号: A61K36/185 , A61K31/155 , A61K35/644 , A61K36/22 , A61K36/268 , A61K36/284 , A61K36/355 , A61K36/49 , A61K36/82 , A61K36/898 , A61P17/02
摘要: A pharmaceutical composition for treating oral ulcer, a preparation method and an application thereof are provided, which belong to the technical field of pharmaceutical compositions. The pharmaceutical composition includes the following raw materials: 20-50 parts of Sanhuang mixture, 15-20 parts of lotus root powder, 30-50 parts of Galla chinensis, 10-20 parts of Lonicera japonica Thunb., 10-20 parts of vanilla bean, 10-20 parts of propolis, 5-8 parts of oak bark, 5-10 parts of tea, 3-5 parts of Asarum, 1-2 parts of Atractylodes macrocephala and 5-30 parts of chlorhexidine acetate. The pharmaceutical composition for treating oral ulcer has the efficacies of clearing away heat, detoxifying removing blood stasis and reducing swelling, promoting granulation and relieving pain, inhibiting bacteria and killing bacteria, and has the advantages of quick response, easy finding of raw materials and low cost, and has a good therapeutic effect for treating oral ulcer clinically.
-
公开(公告)号:US20230285314A1
公开(公告)日:2023-09-14
申请号:US18179986
申请日:2023-03-07
IPC分类号: A61K9/70 , A61K36/45 , A61K36/82 , A61K36/185 , A61K36/28 , A61K31/198 , A61K31/4045 , A61K31/352 , A61K31/593 , A61K31/375 , A61K31/4402 , A61K36/22 , A61K47/38 , A61K47/24 , A61K47/36 , A61K47/46 , A61K47/02 , A61K47/10
CPC分类号: A61K9/7007 , A61K36/45 , A61K36/82 , A61K36/185 , A61K36/28 , A61K31/198 , A61K31/4045 , A61K31/352 , A61K31/593 , A61K31/375 , A61K31/4402 , A61K36/22 , A61K47/38 , A61K47/24 , A61K47/36 , A61K47/46 , A61K47/02 , A61K47/10
摘要: Provided herein are dissolvable compositions. Further provided herein are dissolvable compositions comprising prebiotics. Further provided herein are methods of printing dissolvable compositions.
-
7.
公开(公告)号:US20180318345A1
公开(公告)日:2018-11-08
申请号:US16029423
申请日:2018-07-06
申请人: LiveLeaf, Inc.
发明人: Alexander Huang , Gin Wu
IPC分类号: A61K33/40 , A61K31/352 , A61K31/353 , A61K31/7048 , A61K36/185 , A61K31/7034 , A61K36/22 , A61K45/06 , A61K31/7028 , A61K31/192 , A61K36/82
CPC分类号: A61K33/40 , A61K31/192 , A61K31/352 , A61K31/353 , A61K31/7028 , A61K31/7034 , A61K31/7048 , A61K36/185 , A61K36/22 , A61K36/82 , A61K45/06 , A61K2300/00
摘要: Methods of inhibiting the virulence of a pathogen to treat a gastrointestinal spasm in a subject, without killing the pathogen, are provided. The methods can include administering an effective amount of a formulation to treat the gastrointestinal spasm, the formulation having a tannin combined with a hydroxyl radical in a pharmaceutically acceptable excipient as a binding pair, the tannin releasing in an oxidized state from the hydrogen donor after oral administration of the formulation in the subject; wherein, the composition at least inhibits a gastrointestinal spasm in the subject when compared to a second subject in a control group in which the composition was not administered.
-
公开(公告)号:US20180071351A1
公开(公告)日:2018-03-15
申请号:US15556504
申请日:2016-03-07
申请人: REGENERA PHARMA LTD.
CPC分类号: A61K36/22 , A61K47/06 , A61K47/10 , A61K2236/00
摘要: The invention relates to therapeutic uses of isolated fractions of mastic gum for treating optic neuropathy. More particularly, the invention relates to methods of treating optic neuropathy conditions using compositions comprising isolated fractions of mastic gum.
-
公开(公告)号:US20170252387A1
公开(公告)日:2017-09-07
申请号:US15486964
申请日:2017-04-13
申请人: REGENERA PHARMA LTD.
发明人: Zadik HAZAN , Shimon AMSELEM
IPC分类号: A61K36/22
CPC分类号: A61K36/22
摘要: Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
-
公开(公告)号:US09700546B2
公开(公告)日:2017-07-11
申请号:US14793657
申请日:2015-07-07
发明人: Xiaoming X. Chien , Debasis Bagchi
IPC分类号: A61K31/28 , A61K31/4406 , A61K33/24 , A61K36/185 , A61K36/22 , A61K36/38 , A61K36/49 , A61K36/54 , A61K36/82 , C07C57/44 , C07C59/285 , C07C65/03 , C07C229/76
CPC分类号: A61K31/4406 , A61K31/28 , A61K33/24 , A61K36/185 , A61K36/22 , A61K36/38 , A61K36/49 , A61K36/54 , A61K36/82 , C07C57/44 , C07C59/285 , C07C65/03 , C07C229/76 , A61K2300/00
摘要: The present invention provides chromium compounds, specifically chromium dinicocysteinate, which possess the ability to improve insulin sensitization, glucose tolerance, bioavailability, efficacy, and safety, and methods for their use.
-
-
-
-
-
-
-
-
-